Klaus D. Haegele - Concepedia

Author

Klaus D. Haegele

Also Known As

K D Haegele, K Haegele, K. A. Haegele, K. D. HAEGELE, K. D. Haegele, K. HAEGELE, K. Haegele, K.D. Haegele, KLAUS D. HAEGELE, KLAUS HAEGELE

105

Publications

2.6K

Citations

H-Index

Concepts

All Affiliations

Fondation Jean-Marie Lehn The University of Texas Health Science Center at San Antonio Baylor College of Medicine

About

Klaus D. Haegele is an author at Fondation Jean-Marie Lehn specializing in pharmacology, medicine, and analytical chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	26	1.1K
2	Engineering	9	9	629
3	Natural Sciences	8	8	453
4	Health Sciences	4	4	119
5	Public Health	1	1	384

Klaus D. Haegele

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Atmospheric pressure ionization mass spectrometry. Corona discharge ion source for use in a liquid chromatograph-mass spectrometer-computer analytical system D. I. Carroll, I. Džidić, R. N. Stillwell, Analytical Chemistry EngineeringAnalytical InstrumentationGas ChromatographyAtmospheric ScienceMass Spectrometry	1975	384
Atmospheric Pressure Ionization (API) Mass Spectrometry. Solvent-Mediated Ionization of Samples Introduced in Solution and in a Liquid Chromatograph Effluent Stream E. C. Horning, D. I. Carroll, I. Džidić, Journal of Chromatographic Science Clinical Mass SpectrometryBiological Mass SpectrometryIon Mobility SpectrometryAtmospheric Pressure IonizationChemistry	1974	201
Liquid chromatograph—mass spectrometer—computer analytical systems E. C. Horning, D. I. Carroll, I. Džidić, Journal of Chromatography A BiochemistryGas ChromatographyMass SpectrometryAnalytical ChemistryLiquid Chromatography	1974	172
Failure sequences in the solid phase synthesis of polypeptides Ernst Bayer, Heiner Eckstein, Klaus D. Haegele, Journal of the American Chemical Society EngineeringChemical AnalysisPolypeptidesernst BayerAltmetric Attention ScoreOrganic Chemistry	1970	114
Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer Klaus D. Haegele, Paul J. Schechter Clinical Pharmacology & Therapeutics	1986	90
Excretion Pathways of Amphotericin B Philip C. Craven, Thomas M. Ludden, David J. Drutz, The Journal of Infectious Diseases	1979	85
Effects of single doses of vigabatrin on CSF concentrations of GABA, homocarnosine, homovanillic acid and 5-hydroxyindoleacetic acid in patients with complex partial epilepsy Elinor Ben Menachem, Lennart Persson, Paul J. Schechter, Epilepsy Research Complex Partial EpilepsyNeurophysiologyCsf ConcentrationsSingle DosesMedicine	1988	78
Kinetics of α-difluoromethylornithine: An irreversible inhibitor of ornithine decarboxylase Klaus D. Haegele, R. G. Alken, Jeffrey Grove, Clinical Pharmacology & Therapeutics	1981	77
A cardioselective, hydrophilic N,N,N-trimethylethanaminium .alpha.-tocopherol analog that reduces myocardial infarct size J. Martin Grisar, Margaret A. Petty, Frank N. Bolkenius, Journal of Medicinal Chemistry Cardiovascular DiseaseN-trimethylethanaminium .Alpha.-tocopherol AnalogPharmacologyCardiovascular PharmacologyAltmetric Attention Score	1991	72
Pharmacokinetics of vigabatrin: Implications of creatinine clearance Klaus D. Haegele, Norman Huebert, Marc Ebel, Clinical Pharmacology & Therapeutics	1988	70

Page 1